Guardian Pharmacy converts 39,865 insider shares

After conversion, Guardian Pharmacy Services’ Senior Vice President, Technology, Data & Senior Security Officer reported 140,905 Class A shares and 0 Class B shares.

Rhea-AI Filing Summary

At Guardian Pharmacy Services, Inc., Senior Vice President, Technology, Data & Senior Security Officer David Norman Martin’s 39,865 Class B common shares automatically converted into 39,865 Class A common shares on September 27, 2026, on a one-for-one basis under the company’s Amended and Restated Certificate of Incorporation.

Insider Trade Summary

39,865 shares exercised/converted

Exercise 2 txns

Insider Martin David Norman

Role See Remarks

Type	Security	Shares	Price	Value
Exercise	Class B Common Stock F1	39,865	--	--
Exercise	Class A Common Stock F1	39,865	--	--

Holdings After Transaction: Class B Common Stock — 0 contracts (Direct); Class A Common Stock — 140,905 shares (Direct)

Footnotes (1)

1. F1. Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically converted into shares of the Issuer's Class A common stock, on a one-for-one basis, on September 27, 2026.

Key Figures

Class B common shares converted: 39,865 shares Class A common shares acquired by conversion: 39,865 shares Class A common shares following transaction: 140,905 shares +2 more

5 metrics

Class B common shares converted 39,865 shares Automatic conversion on September 27, 2026

Class A common shares acquired by conversion 39,865 shares Automatic conversion on September 27, 2026

Class A common shares following transaction 140,905 shares Reported following the September 27, 2026 conversion

Class B common shares following transaction 0 shares Reported following the September 27, 2026 conversion

Conversion ratio One-for-one Class B common shares converted into Class A common shares

Key Terms

Amended and Restated Certificate of Incorporation, one-for-one basis, automatically converted

3 terms

Amended and Restated Certificate of Incorporation technical

"under the company’s Amended and Restated Certificate of Incorporation"

A company’s amended and restated certificate of incorporation is an updated version of its foundational legal charter that replaces the older document and folds in all changes into one clear copy; it spells out corporate structure, classes of stock, shareholder rights and key governance rules. Investors care because it can change who controls the company, how votes are counted, what claims shareholders have on assets or dividends, and can introduce or remove protections against takeovers—like updating a house title after a major renovation to show who owns what and under what rules.

one-for-one basis technical

"automatically converted ... on a one-for-one basis"

automatically converted technical

"shares ... automatically converted into shares"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What happened to GRDN Class B shares?

On September 27, 2026, 39,865 Class B common shares held by David Norman Martin automatically converted into 39,865 Class A common shares on a one-for-one basis under Guardian Pharmacy Services’ Amended and Restated Certificate of Incorporation.

How many GRDN shares did David Norman Martin report after the conversion?

After the September 27, 2026 conversion, David Norman Martin reported 140,905 Class A common shares and 0 Class B common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/28/2026 - 05:12 PM Accepted by SEC EDGAR 09/28/2026 - 05:12 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Martin David Norman

(Last) (First) (Middle)

300 GALLERIA PARKWAY SE, SUITE 800

(Street)

ATLANTA GEORGIA 30339

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Guardian Pharmacy Services, Inc. [ GRDN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/27/2026		M		39,865	A	(1)	140,905	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Class B Common Stock	(1)	09/27/2026		M			39,865	(1)	(1)	Class A Common Stock	39,865	(1)	0	D

Explanation of Responses:

1. Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically converted into shares of the Issuer's Class A common stock, on a one-for-one basis, on September 27, 2026.

Remarks:

Senior Vice President, Technology, Data & Senior Security Officer

	/s/ Douglas Towns, Attorney-in-Fact	09/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)